Position in LLY
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$12,144,229
+$4,162,466 QoQ
Shares Held
10,125
+16.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.16%
of 13F equity value
Holder Rank
#1,149
of 4,601 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 92%
Shared 0%
None 8%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NBT BANK N A /NY holds $77,731,381 across 13 Drug Manufacturers - General names. LLY ranks #3 (15.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
104,249 | $26,476,117 | |
| 2 | ABBV |
AbbVie Inc.
|
49,973 | $12,575,205 | |
| 3 | LLY |
ELI LILLY & Co
This page
|
10,125 | $12,144,229 | |
| 4 | MRK |
Merck & Co., Inc.
|
87,583 | $11,254,415 | |
| 5 | NVS |
Novartis AG
|
27,417 | $4,296,791 | |
| 6 | PFE |
Pfizer Inc
|
152,177 | $3,664,421 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
52,754 | $3,039,684 | |
| 8 | AMGN |
Amgen Inc
|
3,761 | $1,361,932 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,144,229 | 10,125 | Shares | Defined | 2026-07-29 | |
| 2026-03-31 | $7,981,763 | 8,678 | Shares | Defined | 2026-04-28 | |
| 2025-12-31 | $9,539,958 | 10,804 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $7,483,371 | 10,441 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $8,300,434 | 10,648 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $8,605,155 | 10,419 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $7,896,016 | 10,228 | Shares | Defined | 2025-02-07 | |
| 2024-09-30 | $9,111,006 | 10,284 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $9,788,968 | 10,812 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $7,567,994 | 9,728 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $5,756,916 | 9,876 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $4,896,476 | 9,116 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $3,508,439 | 7,481 | Shares | Sole | 2023-07-24 | |
| 2023-03-31 | $2,677,301 | 7,796 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $2,927,817 | 8,003 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $2,600,703 | 8,043 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $2,611,348 | 8,054 | Shares | Sole | 2022-07-26 | |
| 2022-03-31 | $2,310,718 | 8,069 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $2,244,286 | 8,125 | Shares | Sole | 2022-01-27 | |
| 2021-09-30 | $1,876,125 | 8,120 | Shares | Sole | 2021-10-18 | |
| 2021-06-30 | $1,867,145 | 8,135 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $1,519,780 | 8,135 | Shares | Sole | 2021-04-08 | |
| 2020-12-31 | $1,391,241 | 8,240 | Shares | Sole | 2021-01-15 | |
| 2020-09-30 | $1,595,211 | 10,777 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $1,359,245 | 8,279 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $1,150,543 | 8,294 | Shares | Sole | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||